GNOM Global X Genomics & Biotechnology ETF Forecast, Technical & Fundamental Analysis
The investment seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Genomics Index ("underlying index")... Show more
GNOM's MACD Histogram crosses above signal line
The Moving Average Convergence Divergence (MACD) for GNOM turned positive on September 22, 2025. Looking at past instances where GNOM's MACD turned positive, the stock continued to rise in of 51 cases over the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on September 22, 2025. You may want to consider a long position or call options on GNOM as a result. In of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The 50-day moving average for GNOM moved above the 200-day moving average on September 11, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GNOM advanced for three days, in of 270 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 180 cases where GNOM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
Bearish Trend Analysis
The 10-day RSI Indicator for GNOM moved out of overbought territory on September 08, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 18 similar instances where the indicator moved out of overbought territory. In of the 18 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where GNOM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
GNOM broke above its upper Bollinger Band on September 05, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Advertisement
General Information
Category Health
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FIJYX | 35.53 | 0.94 | +2.72% |
| Fidelity Advisor Biotechnology Z | |||
| FCDIX | 40.68 | 0.54 | +1.35% |
| Fidelity Advisor Stock Selector Sm Cp I | |||
| IMCVX | 9.85 | 0.11 | +1.13% |
| Voya Multi-Manager Mid Cap Value I | |||
| BBMIX | 11.68 | 0.09 | +0.78% |
| BBH Select Series - Mid Cap I | |||
| LYRWX | 14.53 | 0.10 | +0.69% |
| Lyrical International Value Equity Instl | |||
GNOM and ETFs
Correlation & Price change
A.I.dvisor indicates that over the last year, GNOM has been closely correlated with XBI. These tickers have moved in lockstep 90% of the time. This A.I.-generated data suggests there is a high statistical probability that if GNOM jumps, then XBI could also see price increases.
| Ticker / NAME | Correlation To GNOM | 1D Price Change % | ||
|---|---|---|---|---|
| GNOM | 100% | +1.40% | ||
| XBI - GNOM | 90% Closely correlated | +2.18% | ||
| IBB - GNOM | 87% Closely correlated | +1.36% | ||
| VHT - GNOM | 71% Closely correlated | +1.16% | ||
| IYH - GNOM | 68% Closely correlated | +0.95% | ||
| IXJ - GNOM | 66% Closely correlated | +0.84% | ||
More | ||||